Urinary
tract infections
Terms Cystitis Pyelonephritis
Aetiology
Vesicoureteric reflux Male/
female
Any anatomical
abnormality of the tract, eg tumour, scaring
Enlarged prostate Stasis
Catheters and
instrumentation Stones
- bacteria get into the stones
Glucosuria Start
of sexual activity in women
Haematogenic
infections are also possible
Common pathogens
Coliform infection -
Escherichia coli, Streptococcus faecalis, Proteus, Pseudomonas
Diagnosis
Lower tract infection
- detection of pus cells, detection of nitrite
Prevent contamination
of MSU by preventing contact with adjacent tissues
EMU to look for TB MSU
for C and S
IVP Ultrasound
Isotope studies Cystoscopy
Pathophysiology
Bacterial infection
of the urothelial surface
Interstitial cystitis
may develop in the bladder wall with clear cultures - mostly in middle aged
women
Asymptomatic
bacteriuria occur in 5 - 10% of women and is probably caused by sex
Clinical features Blood and pus in urine
Cystitis frequency, dysuria, urgency
Acute Pyelonephritis
loin pain, fever, malaise, usually
bilateral
Chronic Pyelonephritis
The end result of
chronic infection often from childhood
Small, distorted
asymmetrical kidneys Loin
pain and tenderness
Possible hypertension Question
about intake of NSAIDs
Culture, antibiotics,
creatinine clearance tests
Prevention
Adequate fluid intake Ensure
bladder is fully emptied Empty
bladder after sex
Pregnancy
UTIs are common in
pregnancy May
ascend to the kidneys leading to premature delivery
Should be screened
for bacteria in urine at first prenatal visit and given antibiotics if
indicated
In children
2% of boys and 8% of
girls develop UTIs in childhood
Reflux may cause UTI
Vesicoureteric reflux
present in 8 - 40% of cases
Renal scaring may
develop
Always culture if any
suspicion of UTI
Refer all children
with UTI for investigations
Treatments
High fluid intake Antibiotics Prophylactic
antibiotics Surgery
DEFINITION
UTI
is defined by the presence of a pure growth of more than 105 colony
forming units of bacteria per ml. Lower counts of bacteria may be clinically
important, especially in boys and in specimens obtained by urinary catheter.
Any growth of typical urinary pathogens is considered clinically important if
obtained by suprapubic aspiration. In practice, three age ranges are usually
considered on the basis of differential risk and different approaches to
management: children under 1 year; young children (1–4, 5, or 7 years,
depending on the information source); and older children (up to 12–16
years). Recurrent UTI is defined as a further infection by a new organism.
Relapsing UTI is defined as a further infection with the same organism.
PREVALENCE
Boys
are more susceptible before the age of 3 months; thereafter the incidence is
substantially higher in girls. Estimates of the true incidence of UTI depend on
rates of diagnosis and investigation. At least 8% of girls and 2% of boys will
have a UTI in childhood.
AETIOLOGY
The
normal urinary tract is sterile. Contamination by bowel flora may result in
urinary infection if a virulent organism is involved or if the child is
immunosuppressed. In neonates, infection may originate from other sources. Escherichia
coli accounts for about three quarters of all pathogens. Proteus
is more common in boys (about 30% of infections). Obstructive anomalies are
found in 0–4% and vesicoureteric reflux in 8–40% of children being
investigated for their first UTI. Although vesicoureteric reflux is a major
risk factor for adverse outcome, other as yet unidentified triggers may also
need to be present.
PROGNOSIS After
first infection, about half of girls have a further infection in the first year
and three quarters within 2 years. We found no figures for boys, but a review
suggests that recurrences are common under 1 year of age but rare subsequently.
Renal scarring occurs in 5–15% of children within 1–2 years of
their first UTI, although 32–70% of these scars are noted at the time of
initial assessment. The incidence of renal scarring rises with each episode of
infection in childhood. An RCT comparing oral versus intravenous antibiotics
found retrospectively that new renal scarring after a first UTI was more common
in children with vesicoureteric reflux than in children without reflux
(logistic regression model: AR of scarring 16/107 [15.0%] with reflux v
10/165 [6%] without reflux; RR 2.47, 95% CI 1.17 to 5.24). A study (287
children with severe vesicoureteral reflux treated either medically or
surgically for any UTI) evaluated the risk of renal scarring with serial DMSA![]()
scintigraphy over 5 years. It found that
younger children (under 2 years) were at greater risk of renal scarring than
older children regardless of treatment allocation for the infection (AR for
deterioration in DMSA scan over 5 years 21/86 for younger children v
27/201 for older children; RR 1.82, 95% CI 1.09 to 3.03). Renal scarring is
associated with future complications: poor renal growth; recurrent adult
pyelonephritis; impaired glomerular function; early hypertension; and end stage
renal failure. A combination of recurrent urinary infection, severe
vesicoureteric reflux, and the presence of renal scarring at first presentation
is associated with the worst prognosis.
AIMS
To relieve acute
symptoms; to eliminate infection; and to prevent recurrence, renal damage, and
long term complications.
OUTCOMES
Short term: clinical symptoms and signs (dysuria, frequency, fever);
urine culture; incidence of new renal scars. Long term: incidence of recurrent infection; prevalence of renal
scarring; renal size and growth; renal function; prevalence of hypertension and
renal failure.
UTIs in children
Aetiology
Vesicoureteric reflex
is most common
Congenital
obstructions
Bladder dysfunctions
Some forms of E. coli
may adhere to the urinary endothelium so are not easily washed out
Presentation
Neonates
In neonates this is non-specific,
e.g. poor feeding, vomiting, irratibility
May develop into
sepsis with meningitis
Post neonatal
In young children
presentation may include fever, irritability, diarrhoea, vomiting.
Features may look
like a GI rather than a GU problem.
Frequency and dysuria
are not reliable symptoms.
May or may not be
suprapubic or loin tenderness.
School age children
More classical adult
type presentation
Inflammatory features
around the urethral orifice
Diagnosis
Microscopy and
culture and sensitivity testing
Ward based tests for
blood, protein, white cells and nitrite are indicative
Collect a clean
specamine
Suprapubic samples
being the most reliable, used under 1 year, best taken when the bladder is full
Management
In young children
i.v. antibiotics to reduce the risk of disseminated infection
While waiting for
sensitivity consider trimethoprim, cephalosporins, amoxicillin with clavulinic
acid
Repeat C and S at the
end of the antibiotic course to confirm resolution
Follow-up
investigations of the urinary tract such isotope scanning, ultrasound scanning
Renal scaring (reflux
nephropathy) is most likely in the first 5 years of life, the younger the child
the more sensitive the kidneys
Scaring may lead to
chronic renal insufficiency and hypertension
Over the age of 5
pre-existing renal scars may enlarge with repeated infection but new scars
rarely occur.
Recurrent infections
over the age of 5 do not cause renal scar formation
If there is vesicoureteric
reflex put the child on prophylactic antibiotics for at least 2 years, probably
more, consider trimethoprim or nitrofurantoin, once at night
Treat acute
infections promptly
Surgical re
implantation of the ureters may be considered in extreme cases
Vesicoureteric reflex
usually resolves with a rate of about 10% per year
Other causes of UTI
Other causes of
infection below the age of 5 years may also lead to renal scaring,
Therefore children
must be well investigated after UTIs
Remember chronic pyelonephritis is a common indication of
renal dialysis in later life and almost certainly has its origins before the
age of 5 years.
Haemolytic uraemic
syndrome (HUS)
Pathophysiology
Intravascular haemolysis with red cell fragmentation
Microangiopathic haemolysis
Thrombocytopenia
Acute renal failure caused by thrombosis in small arteries
and arterioles
Microthrombi occlude small renal vessels
Microthrombi may also occlude cerebral vessels leading to
RICP with reduced GCS
Aetiology
Usually Escherichia coli, usually 0157
Evolution
Febrile illness, often with gastroenteritis (known as
diarrhoea associated HUS
HUS develops after the febrile episode
Most patients recover renal function
Acute mortality is 5%
5% develop chronic renal failure
30% exhibit long term renal damage with proteinuria
Management
Prevent cross infection
Supportive therapy until renal function recovers
Fluid end electrolyte balance, antihypertensive medication,
nutritional support, probably dialysis
Id antibiotic or antimotility drugs are used to treat the
diarrhoea there is a greater risk HUS and its complications